NCPE Recommends Conditional Access for Omeprazole
NCPE recommends Omeprazole Appizped for reimbursement eligibility.
Read MorePosted by Shajini | Jul 1, 2025 | News, Pricing & Market Access
NCPE recommends Omeprazole Appizped for reimbursement eligibility.
Read MorePosted by Shajini | Jul 1, 2025 | News, Pricing & Market Access
NCPE recommends Vabysmo for neovascular (wet) age-related macular degeneration treatment.
Read MorePosted by Shajini | Jun 27, 2025 | News, Orthopaedics
J&J invests $100M in AI in surgery funding to drive smarter surgical solutions.
Read MorePosted by Shajini | Jun 27, 2025 | FDA Updates, News, Orthopaedics |
Stryker FDA-cleared InCompass Ankle; protein degrader partnerships drive innovation.
Read MorePosted by Shajini | Jun 27, 2025 | Dealstreet, News |
Sanofi, Gilead sign License Agreement with Kymera for protein degrader programs.
Read More